Statistics for Veracyte (id:6442 VCYT)

Valuation metrics

Market cap

2.79B

Enterprise value

2.53B

Trailing P/E (ttm)

-38.43

Forward P/E

89.85

PEG ratio

89.85

Price/Sales (ttm)

6.55

Price/Book (mrq)

2.37

Enterprise Value/Revenue

5.95

Enterprise Value/EBITDA

57.51

Overview

Shares outstanding

77.50M

Float

77.15M

Shares short

3.10M

% Held by insiders

0.01%

% Held by institutions

1.04%

Average volume (10 days)

1.12M

Average volume (90 days)

Price summary

52-Week low

18.61

52-Week high

41.43

52-Week change

33.37%

Beta

1.67

50-Day moving average

34.06

200-Day moving average

26.05

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-2.18%

Operating margin

10.53%

Operational effectiveness

Return on assets

1.07%

Return on equity

-0.83%

Income statement

Revenue (ttm)

5.64

Revenue per share (ttm)

5.64

Quarterly revenue growth (yoy)

Gross profit (ttm)

248.15M

EBITDA

45.91M

Net income to common (ttm)

-9,268,000.00

Diluted EPS (ttm)

-0.13

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

274.08M

Total cash per share (mrq)

3.54

Total debt (mrq)

19.79M

Total Debt/Equity (mrq)

1.68

Current ratio (mrq)

507.50%

Book value per share (mrq)

15.18

Cash flow

Cash flow statement

66.12M

Levered free cash flow (LFCF)

57.26M